Burkitt Lymphoma - Pipeline Review, H2 2014 th
On 24 September 2014
Summary Burkitt Lymphoma - Pipeline Review, H2 2014, provides an overview of the Burkitt Lymphomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Burkitt Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Burkitt Lymphoma and special features on latestage and discontinued projects.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-Burkitt-Lymphoma-Pipeline-Review-H2-2014-125486 Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope - The report provides a snapshot of the global therapeutic landscape of Burkitt Lymphoma - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Burkitt Lymphoma and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Burkitt Lymphoma products under development by companies and universities/research institutes based on information derived from company and industryspecific sources - Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Burkitt Lymphoma pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products
Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Burkitt Lymphoma - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Burkitt Lymphoma pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Table of Content List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Burkitt Lymphoma Overview 6 Therapeutics Development 7 Pipeline Products for Burkitt Lymphoma - Overview 7 Pipeline Products for Burkitt Lymphoma - Comparative Analysis 8 Burkitt Lymphoma - Therapeutics under Development by Companies 9 Burkitt Lymphoma - Therapeutics under Investigation by Universities/Institutes 10 Burkitt Lymphoma - Pipeline Products Glance 11 Clinical Stage Products 11 Early Stage Products 12 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Burkitt Lymphoma - Products under Development by Companies 13 Burkitt Lymphoma - Products under Investigation by Universities/Institutes 14 Burkitt Lymphoma - Companies Involved in Therapeutics Development 15 AstraZeneca PLC 15 Seattle Genetics, Inc. 16 Celldex Therapeutics, Inc. 17 Constellation Pharmaceuticals, Inc. 18 Burkitt Lymphoma - Therapeutics Assessment 19 Assessment by Monotherapy Products 19 Assessment by Target 20 Assessment by Mechanism of Action 22 Assessment by Route of Administration 24 Assessment by Molecule Type 26 Drug Profiles 28 varlilumab - Drug Profile 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 SGN-CD19A - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 NSC-678515 - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 AZD-6738 - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 SH-7139 - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 Small Molecules to Inhibit BET for Cancer - Drug Profile 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Monoclonal Antibody Conjugated to Target CD20 for CLL and Burkitt Lymphoma - Drug Profile Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
36 Product Description 36 Mechanism of Action 36 R&D Progress 36 M-921 - Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 SH-7133 - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 SH-7129 - Drug Profile 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 Burkitt Lymphoma - Recent Pipeline Updates 41 Appendix 46 Methodology 46 Coverage 46 Secondary Research 46 Primary Research 46 Expert Panel Validation 46 Contact Us 47 Disclaimer 47 List Of Tables Number of Products under Development for Burkitt Lymphoma, H2 2014 7 Number of Products under Development for Burkitt Lymphoma - Comparative Analysis, H2 2014 8 Number of Products under Development by Companies, H2 2014 9 Number of Products under Investigation by Universities/Institutes, H2 2014 10 Comparative Analysis by Clinical Stage Development, H2 2014 11 Comparative Analysis by Early Stage Development, H2 2014 12 Products under Development by Companies, H2 2014 13 Products under Investigation by Universities/Institutes, H2 2014 14 Burkitt Lymphoma - Pipeline by AstraZeneca PLC, H2 2014 15 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Burkitt Lymphoma - Pipeline by Seattle Genetics, Inc., H2 2014 16 Burkitt Lymphoma - Pipeline by Celldex Therapeutics, Inc., H2 2014 17 Burkitt Lymphoma - Pipeline by Constellation Pharmaceuticals, Inc., H2 2014 18 Assessment by Monotherapy Products, H2 2014 19 Number of Products by Stage and Target, H2 2014 21 Number of Products by Stage and Mechanism of Action, H2 2014 23 Number of Products by Stage and Route of Administration, H2 2014 25 Number of Products by Stage and Molecule Type, H2 2014 27 Burkitt Lymphoma Therapeutics - Recent Pipeline Updates, H2 2014 41 List Of Figures Number of Products under Development for Burkitt Lymphoma, H2 2014 7 Number of Products under Development for Burkitt Lymphoma - Comparative Analysis, H2 2014 8 Number of Products under Development by Companies, H2 2014 9 Number of Products under Investigation by Universities/Institutes, H2 2014 10 Comparative Analysis by Clinical Stage Development, H2 2014 11 Comparative Analysis by Early Stage Products, H2 2014 12 Assessment by Monotherapy Products, H2 2014 19 Number of Products by Top 10 Target, H2 2014 20 Number of Products by Stage and Top 10 Target, H2 2014 21 Number of Products by Top 10 Mechanism of Action, H2 2014 22 Number of Products by Stage and Top 10 Mechanism of Action, H2 2014 23 Number of Products by Top 10 Route of Administration, H2 2014 24 Number of Products by Stage and Top 10 Route of Administration, H2 2014 25 Number of Products by Top 10 Molecule Type, H2 2014 26 Number of Products by Stage and Top 10 Molecule Type, H2 2014 27
Report Price: Licence Type
Price
$ 2000
Site Licence Price
$ 4000
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Enterprise Wide Licence
$ 6000
Related Reports: Alethia Biotherapeutics Inc. - Product Pipeline Review - 2014 Celsus Therapeutics Plc - Product Pipeline Review - 2014 FAES Farma SA - Product Pipeline Review - 2014 Genextra S.p.a. - Product Pipeline Review - 2014 Molecular Design International, Inc. - Product Pipeline Review - 2014 TaiGen Biotechnology Co., Ltd. - Product Pipeline Review - 2014 Zosano, Inc. - Product Pipeline Review - 2014 ProteoTech, Inc. - Product Pipeline Review - 2014 Clera Inc. - Product Pipeline Review - 2014 Errant Gene Therapeutics, LLC - Product Pipeline Review - 2014
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Burkitt Lymphoma - Pipeline Review, H2 2014 http://www.jsbmarketresearch.com/healthcare-medical/r-Burkitt-LymphomaPipeline-Review-H2-2014-125486
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/